Primary Myelofibrosis (PMF) Withdrawn Phase 1 Trials for Tacrolimus (DB00864)

Also known as: Primary Myelofibrosis / Primary Myelofibrosis (MF) / Myelofibrosis (PMF) / Myelofibrosis, Primary / PMF / Osteomyelofibrosis / Primary myelofibrosis (disorder) / Myelofibrosis (disorder) / Primary myelofibrosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0044387 (Primary Myelofibrosis (PMF))Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02528877Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisSupportive Care